recurrent stenosis . angioplasty in patients at high risk of Verapamil treatment after coronary
暂无分享,去创建一个
G. Schuler | A. Schomig | R. Dietz | H. Katus | J. Niebauer | F. Schwarz | B. Rauch | W. Kubler | E. Hoberg | H. Tillmanns | U. Frees
[1] B Meier,et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. , 1986, Circulation.
[2] C Vallbracht,et al. Recurrence rate after successful coronary angioplasty. , 1985, European heart journal.
[3] O. Stein,et al. Long‐Term Effects of Verapamil on Aortic Smooth Muscle Cells Cultured in the Presence of Hypercholesterolemic Serum , 1987, Arteriosclerosis.
[4] V. Fuster,et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.
[5] M. Bourassa,et al. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. , 1985, Journal of the American College of Cardiology.
[6] M. Nobuyoshi,et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.
[7] M. Bertrand,et al. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. , 1986, Journal of the American College of Cardiology.
[8] C. Stiles,et al. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors. , 1980, Journal of supramolecular structure.
[9] Spencer B. King,et al. Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .
[10] B. Chaitman,et al. Multilesion coronary angioplasty: clinical and angiographic follow-up. , 1987, Journal of the American College of Cardiology.
[11] P. Serruys,et al. Restenosis after coronary angioplasty: new standards for clinical studies. , 1990, Journal of the American College of Cardiology.
[12] E. Jones,et al. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. , 1990, Circulation.
[13] C. Jackson,et al. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. , 1988, Atherosclerosis.
[14] R E Vlietstra,et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.
[15] L Morgenstern,et al. Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.
[16] S. Mutoh,et al. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery. , 1987, Atherosclerosis.
[17] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.
[18] B. Meier,et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. , 1986, Journal of the American College of Cardiology.
[19] M. Aschermann. [Restenosis after percutaneous transluminal coronary angioplasty]. , 1990, Casopis lekaru ceskych.
[20] S Levine,et al. Coronary angioplasty: clinical and angiographic follow-up. , 1985, The American journal of cardiology.
[21] M. Bourassa,et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. , 1985, American heart journal.
[22] W. Vetter,et al. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Schuler,et al. Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease , 1992, Circulation.
[24] C. Simpfendorfer,et al. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. , 1987, The American journal of cardiology.
[25] J. O’Keefe,et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. , 1991, The American journal of cardiology.
[26] L. Elveback,et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. , 1985, Circulation.
[27] S. Schwartz,et al. Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.